Literature DB >> 20425228

Seizures and epilepsy in cancer patients.

Edward K Avila1, Jerome Graber.   

Abstract

Seizures in the general population may occur for a variety of reasons, including vascular, infectious, autoimmune, genetic, and traumatic causes. In the cancer population, seizures arise mainly as a result of an infiltrative neoplastic process in the brain. However, seizures as a result of cancer treatment, metabolic causes, or paraneoplastic diseases may occur in patients with systemic cancer, even in the absence of a cerebral lesion. The etiology of seizures in brain tumor patients includes primary cerebral neoplasms and metastatic brain lesions. The treatment for seizures in this population is multifaceted and involves surgery, radiation, chemotherapy, and antiepileptic drugs. All treatments have potential adverse effects, especially when combined. The treatment for brain tumor-associated seizures and epilepsy almost always is geared toward treating the tumor, but subsequent treatment of seizures often is necessary. A pragmatic approach to this problem is essential to mitigate potential complications from treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425228     DOI: 10.1007/s11910-009-0080-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  47 in total

Review 1.  Continuous EEG monitoring in the intensive care unit: an overview.

Authors:  Lawrence J Hirsch
Journal:  J Clin Neurophysiol       Date:  2004 Sep-Oct       Impact factor: 2.177

Review 2.  Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.

Authors:  Melanie S M van Breemen; Erik B Wilms; Charles J Vecht
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

Review 3.  Epilepsy and brain tumors: implications for treatment.

Authors:  G D Cascino
Journal:  Epilepsia       Date:  1990       Impact factor: 5.864

4.  The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects.

Authors:  Cordelia Luyken; Ingmar Blümcke; Rolf Fimmers; Horst Urbach; Christian E Elger; Otmar D Wiestler; Johannes Schramm
Journal:  Epilepsia       Date:  2003-06       Impact factor: 5.864

Review 5.  Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota.

Authors:  W A Hauser; J F Annegers; W A Rocca
Journal:  Mayo Clin Proc       Date:  1996-06       Impact factor: 7.616

6.  Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response.

Authors:  A Pace; A Vidiri; E Galiè; M Carosi; S Telera; A M Cianciulli; P Canalini; D Giannarelli; B Jandolo; C M Carapella
Journal:  Ann Oncol       Date:  2003-12       Impact factor: 32.976

7.  Efficacy of anti-epileptic drugs in patients with gliomas and seizures.

Authors:  Mèlanie S M van Breemen; R M Rijsman; M J B Taphoorn; R Walchenbach; H Zwinkels; Charles J Vecht
Journal:  J Neurol       Date:  2009-05-12       Impact factor: 4.849

8.  Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities.

Authors:  Adília Hormigo; Bernardo Liberato; Eric Lis; Lisa M DeAngelis
Journal:  Arch Neurol       Date:  2004-03

9.  EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness.

Authors:  M Privitera; M Hoffman; J L Moore; D Jester
Journal:  Epilepsy Res       Date:  1994-06       Impact factor: 3.045

10.  Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.

Authors:  Daniel A Lim; Phiroz Tarapore; Edward Chang; Marlene Burt; Lenna Chakalian; Nicholas Barbaro; Susan Chang; Kathleen R Lamborn; Michael W McDermott
Journal:  J Neurooncol       Date:  2009-01-24       Impact factor: 4.130

View more
  3 in total

1.  Non-convulsive status epilepticus in brain tumors.

Authors:  M Casazza; I Gilioli
Journal:  Neurol Sci       Date:  2011-11       Impact factor: 3.307

2.  CENTRAL DIABETES INSIPIDUS AND CHEMOTHERAPY: USE OF A CONTINUOUS ARGININE VASOPRESSIN INFUSION FOR FLUID AND SODIUM BALANCE.

Authors:  Joshua A Levine; Susan L Karam; Clare O'Connor; Smita Kumar; Malini Soundarrajan; Deepika McConnell; Abeer T Ammar; Ashley M Gale; Donald Zimmerman; Emily D Szmuilowicz
Journal:  AACE Clin Case Rep       Date:  2018 Nov-Dec

3.  Toxoplasma gondii Infections Alter GABAergic Synapses and Signaling in the Central Nervous System.

Authors:  Justin M Brooks; Gabriela L Carrillo; Jianmin Su; David S Lindsay; Michael A Fox; Ira J Blader
Journal:  mBio       Date:  2015-10-27       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.